NASDAQ
DNAPrint Genomics, Inc. (DNAG) has a free cash flow growth of -12.86% as of Friday, May 29, 2026. This represents a 0.05% increase compared to its 12-month average of -12.87%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.